Human HOXA7 CRISPR Knock Out 293T Cell Line

Cell line type

293T
NCBI number

NM_006896
Availability

Please contact us every day to check the availability and/or to request a quote. For larger or bulk quantities a discount may apply.
Ordering

If you wish to order this product, please include the catalogue number #K0981351in your purchase order among with your shipping and billing information.
Technical file

Please contact us to request the latest datasheet, protocol, certificate of analysis and SDS files.
Notes

Designed for Research Use Only. Manufactured in Canada.
Other products
Description

For cells, cell lines and tissues in culture till half confluency.
Properties

Human proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.

Gene target

HOXA7 CRISPR Knock Out Line
Gene symbol

HOXA7
Short name

HOXA7 CRISPR Knock Out Line
Technique

CV40 transformed cell line or 293tsA1609neo from human kidney 293 cells delivered as 1.
Species

Human, Humans
Alternative name

H. sapiens homeobox A7 CRISPR Knock Out 293T cellular Line
Alternative to gene target

homeobox A7, ANTP and HOX1 and HOX1.1 and HOX1A, HOXA7 and IDBG-10464 and ENSG00000122592 and 3204, sequence-specific DNA binding, nuclei, Hoxa7 and IDBG-147979 and ENSMUSG00000038236 and 15404, BT.99285 and IDBG-633576 and ENSBTAG00000001455 and 615851
Tissue

cell

Name

Transformation, Bacterial
Concept

Scope note: The heritable modification of the properties of a competent bacterium by naked DNA from another source. The uptake of naked DNA is a naturally occuring phenomenon in some bacteria. It is often used as a GENE TRANSFER TECHNIQUE.
Tree numbers
- E05.393.350.810.500
Qualifiers

immunology, physiology, ethics, drug effects, radiation effects, genetics